Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning

Luis Mariano Esteban1,2, Ángel Borque-Fernando3,4,5, Maria Etelvina Escorihuela6

  • 1Department of Applied Mathematics, Escuela Universitaria Politécnica de La Almunia, Universidad de Zaragoza, C/ Mayor 5, 50100, La Almunia de Doña Godina, Spain. lmeste@unizar.es.

Scientific Reports
|February 5, 2025
PubMed
Summary

Advanced machine learning models, including XGBoost, show superior performance in predicting clinically significant prostate cancer (CsPCa) compared to traditional logistic regression. These models can significantly reduce unnecessary biopsies, improving clinical utility and patient outcomes.

Related Concept Videos